AXIOS PRO Exclusive: HyperSpectral bags $9M for pathogen testing

6.6.2024

Pathogen detection startup HyperSpectral raised an $8.5 million Series A led by RRE Ventures and Kibo Ventures, CEO Matt Theurer tells Axios exclusively.

>> NEWSLETTER

Get updates and insight direct to your inbox.

Thanks for subscribing.
Oops! Something went wrong while submitting the form.
We never share your data with third parties.